Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis.
The authors report on the case of a patient with polymyositis who was given immunosuppressive therapy and then developed Kaposi's sarcoma. Subsequently, the polymyositis was treated with high dose intravenous immunoglobulin, and the Kaposi's sarcoma regressed abruptly. The association between these two diseases and the beneficial effect of intravenous immunoglobulin on Kaposi's sarcoma are discussed.
Carmeli
Y
Y
Department of Internal Medicine, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel.
Mevorach
D
D
Kaminski
N
N
Raz
E
E
D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D017285:Polymyositis / Q000150:complications / Q000628:therapy*; D011239:Prednisolone / Q000009:adverse effects; D012514:Sarcoma, Kaposi / Q000209:etiology / Q000628:therapy*
D016756:Immunoglobulins, Intravenous; D011239:Prednisolone; D008727:Methotrexate